BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16289869)

  • 1. Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome.
    Martin-Moutot N; Haro Ld; Santos RG; Mori Y; Seagar M
    Neurobiol Dis; 2006 Apr; 22(1):57-63. PubMed ID: 16289869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.
    Fukuda T; Motomura M; Nakao Y; Shiraishi H; Yoshimura T; Iwanaga K; Tsujihata M; Eguchi K
    Ann Neurol; 2003 Jan; 53(1):21-8. PubMed ID: 12509844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dosage and specificity of anti-calcium channel antibodies in Lambert-Eaton myasthenic syndrome].
    Martin-Moutot N; de Haro L; Seagar M
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S28-34. PubMed ID: 15269657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Leys K; Lang B; Johnston I; Newsom-Davis J
    Ann Neurol; 1991 Mar; 29(3):307-14. PubMed ID: 1645944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Motomura M; Lang B; Johnston I; Palace J; Vincent A; Newsom-Davis J
    J Neurol Sci; 1997 Mar; 147(1):35-42. PubMed ID: 9094058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
    Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
    Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome.
    Houzen H; Hattori Y; Kanno M; Kikuchi S; Tashiro K; Motomura M; Nakao Y; Nakamura T
    Ann Neurol; 1998 May; 43(5):677-80. PubMed ID: 9585366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
    Johnston I; Lang B; Leys K; Newsom-Davis J
    Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
    Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
    Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
    Arsac C; Raymond C; Martin-Moutot N; Dargent B; Couraud F; Pouget J; Seagar M
    Ann Neurol; 1996 Nov; 40(5):695-700. PubMed ID: 8957009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
    Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
    J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.
    Martin-Moutot N; De Haro L; Seagar M
    J Neuroimmunol; 2008 Jun; 197(1):47-53. PubMed ID: 18474401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
    Wirtz PW; Lang B; Graus F; van den Maagdenberg AM; Saiz A; de Koning Gans PA; Twijnstra A; Verschuuren JJ
    J Neuroimmunol; 2005 Jul; 164(1-2):161-5. PubMed ID: 15904978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lambert-Eaton syndrome without calcium channel autoantibodies].
    Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
    Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.
    Motomura M; Johnston I; Lang B; Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):85-7. PubMed ID: 7823075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lambert-Eaton myasthenic syndrome in childhood.
    Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.